United Biomedical, Inc.
Records under this name other than the patents United Biomedical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to United Biomedical, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,102,752 | Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,180,555 | Antibodies directed against CD4 for the treatment and functional cure of HIV Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,084,015 | Stabilized synthetic immunogen delivery system Term ended Term ended Apr 14, 2026 · From the USPTO record | Term ended | Term ended Apr 14, 2026 | From the USPTO record |
| US 9,932,372 | Designer peptide-based PCV2 vaccine Lapsed on the fee record Ended Apr 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2026 | From the USPTO record |
| US 8,088,388 | Stabilized synthetic immunogen delivery system Term ended Term ended Jul 26, 2025 · From the USPTO record | Term ended | Term ended Jul 26, 2025 | From the USPTO record |
| US 7,501,494 | Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection Formerly held Term ended Term ended Sep 20, 2024 · From the USPTO record | Term ended | Term ended Sep 20, 2024 | From the USPTO record |
| US 7,872,110 | Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection Formerly held Term ended Term ended Jan 15, 2023 · From the USPTO record | Term ended | Term ended Jan 15, 2023 | From the USPTO record |
| US 7,951,909 | Immunogenic peptide composition comprising a promiscuous helper T cell epitope and an N-terminal fragment of Aβ1-42 peptide Formerly held Term ended Term ended Jun 24, 2022 · From the USPTO record | Term ended | Term ended Jun 24, 2022 | From the USPTO record |
| US 6,906,169 | Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide Formerly held Term ended Term ended Jun 14, 2022 · From the USPTO record | Term ended | Term ended Jun 14, 2022 | From the USPTO record |
| US 8,232,373 | Immunogenic peptide composition for the prevention and treatment of alzheimer's disease Formerly held Term ended Term ended May 25, 2021 · From the USPTO record | Term ended | Term ended May 25, 2021 | From the USPTO record |